A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities

Evangelia Kounatidou, Sirintra Nakjang, Stuart R.C. McCracken, Scott M. Dehm, Craig N. Robson, Dominic Jones, Luke Gaughan

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities'. Together they form a unique fingerprint.

Medicine & Life Sciences